<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To examine whether and how heart ANG II influences the coordination between cardiomyocyte <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and coronary <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and contributes to the pathogenesis of diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, we used Spontaneously Diabetic Torii (SDT) rats treated without and with <z:chebi fb="0" ids="48416">olmesartan</z:chebi> medoxomil (an ANG II receptor blocker) </plain></SENT>
<SENT sid="1" pm="."><plain>In SDT rats, left ventricular (LV) ANG II, but not circulating ANG II, increased at 8 and 16 wk after <z:mp ids='MP_0002055'>diabetes</z:mp> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>SDT rats developed LV <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and diastolic dysfunction at 8 wk, followed by LV systolic dysfunction at 16 wk, without <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The SDT rat LV exhibited cardiomyocyte <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and increased <z:mp ids='MP_0005039'>hypoxia</z:mp>-inducible factor-1Î± expression at 8 wk and to a greater degree at 16 wk and interstitial <z:mp ids='MP_0003045'>fibrosis</z:mp> at 16 wk only </plain></SENT>
<SENT sid="4" pm="."><plain>In SDT rats, coronary <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> increased with enhanced capillary proliferation and upregulation of the angiogenic factor VEGF at 8 wk but decreased VEGF with enhanced capillary <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and suppressed capillary proliferation despite the upregulation of VEGF at 16 wk </plain></SENT>
<SENT sid="5" pm="."><plain>In SDT rats, the phosphorylation of VEGF receptor-2 increased at 8 wk alone, whereas the expression of the antiangiogenic factor thrombospondin-1 increased at 16 wk alone </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these events, except for <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> or blood pressure, were reversed by <z:chebi fb="0" ids="48416">olmesartan</z:chebi> medoxomil </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that LV ANG II in SDT rats at 8 and 16 wk induces cardiomyocyte <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> without affecting <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> or blood pressure, which promotes and suppresses coronary <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, respectively, via VEGF and thrombospondin-1 produced from hypertrophied cardiomyocytes under <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0005039'>hypoxia</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Thrombospondin-1 may play an important role in the progression of diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> in this model </plain></SENT>
</text></document>